Multi-targeting cancer chemotherapy using temperature-responsive drug carrier systems

2011 ◽  
Vol 71 (3) ◽  
pp. 235-244 ◽  
Author(s):  
Masamichi Nakayama ◽  
Teruo Okano
Keyword(s):  
Cancer Chemotherapy ◽  
Drug Carrier ◽  
Temperature Responsive ◽  
Carrier Systems ◽  
Drug Carrier Systems

Lipids-based drug carrier systems by dense gas technology: A review

2012 ◽  
Vol 188 ◽  
pp. 1-14 ◽  
Author(s):  
Chau Chun Beh ◽  
Raffaella Mammucari ◽  
Neil R. Foster
Keyword(s):  
Drug Carrier ◽  
Dense Gas ◽  
Carrier Systems ◽  
Drug Carrier Systems

Biodegradable Polymers as Drug Carrier Systems

2001 ◽  
Author(s):  
Abraham Domb ◽  
Neeraj Kumar ◽  
Tzviel Sheskin ◽  
Alfonso Bentolila ◽  
Joram Slager ◽  
...  
Keyword(s):  
Biodegradable Polymers ◽  
Drug Carrier ◽  
Carrier Systems ◽  
Drug Carrier Systems

Anticancer Agents: Drug Carrier Systems

2015 ◽  
pp. 228-241
Author(s):  
Hiroyuki Koide ◽  
Tomohiro Asai ◽  
Kosuke Shimizu ◽  
Naoto Oku
Keyword(s):  
Anticancer Agents ◽  
Drug Carrier ◽  
Carrier Systems ◽  
Drug Carrier Systems

scholarly journals Integrin-Targeting Peptides for the Design of Functional Cell-Responsive Biomaterials

Biomedicines ◽  
2020 ◽  
Vol 8 (9) ◽  
pp. 307 ◽  
Author(s):  
Junwei Zhao ◽  
Federica Santino ◽  
Daria Giacomini ◽  
Luca Gentilucci
Keyword(s):  
Cell Surface ◽  
Smart Materials ◽  
Drug Carrier ◽  
Peptide Ligands ◽  
Stimuli Responsive ◽  
Cellular Functions ◽  
Surface Receptors ◽  
Integrin Ligands ◽  
Carrier Systems ◽  
Drug Carrier Systems

Integrins are a family of cell surface receptors crucial to fundamental cellular functions such as adhesion, signaling, and viability, deeply involved in a variety of diseases, including the initiation and progression of cancer, of coronary, inflammatory, or autoimmune diseases. The natural ligands of integrins are glycoproteins expressed on the cell surface or proteins of the extracellular matrix. For this reason, short peptides or peptidomimetic sequences that reproduce the integrin-binding motives have attracted much attention as potential drugs. When challenged in clinical trials, these peptides/peptidomimetics let to contrasting and disappointing results. In the search for alternative utilizations, the integrin peptide ligands have been conjugated onto nanoparticles, materials, or drugs and drug carrier systems, for specific recognition or delivery of drugs to cells overexpressing the targeted integrins. Recent research in peptidic integrin ligands is exploring new opportunities, in particular for the design of nanostructured, micro-fabricated, cell-responsive, stimuli-responsive, smart materials.

Sign in / Sign up

Export Citation Format

Share Document